Table 2.
Fecal Microbiota Transplantation Indication and Related Characteristics
| Characteristics | n (%) |
|---|---|
| FMT indication | |
| CDI | 259 (100) |
| Method of CDI diagnosis | |
| Symptoms and PCR | 163 (63) |
| Symptoms and EIA | 54 (21) |
| Symptoms, EIA and PCR | 20 (8) |
| Symptoms only | 12 (5) |
| PCR only | 8 (3) |
| EIA only | 1 (<1) |
| Not reported | 1 (<1) |
| CDI severity | |
| Mild | 92 (36) |
| Moderate | 115 (44) |
| Severe | 48 (19) |
| Severe-complicated | 2 (1) |
| Not reported | 2 (1) |
| CDI duration | |
| <1 mo | 14 (5) |
| 1–6 mo | 149 (58) |
| 7–12 mo | 61 (24) |
| 13–24 mo | 17 (7) |
| >24 mo | 16 (6) |
| Not reported | 2 (1) |
| No. of prior CDI episodes | |
| 1 | 15 (6) |
| 2 | 34 (13) |
| 3 | 110 (42) |
| 4 | 56 (22) |
| 5 or more | 42 (16) |
| Not reported | 2 (1) |
| Prior treatments for CDI | |
| Vancomycin | 236 (91) |
| Vancomycin taper/pulse | 141 (54) |
| Metronidazole | 104 (40) |
| Fidaxomicin | 73 (28) |
| Probiotics | 44 (17) |
| Other treatments | 14 (5) |
| No prior treatments | 5 (2) |
EIA, enzyme immunoassay; PCR, polymerase chain reaction.